As a provider of custom services, Creative Biolabs aims to support the entire process of drug discovery and development for the global pharmaceutical industry using its cutting-edge technology and wide-ranging experiences.
It is no secret that the complexities associated with biopharmaceuticals are ever increasing, particularly regarding the development of antibody therapeutics. Effective and accurate candidate molecule screening and optimization has become one of the primary challenges for pharmaceutical companies. Through its range of services, Creative Biolabs, in particular, speeds up the overall drug discovery process through antibody drug development.
How Innovation Drives Drug Discovery
Identifying targets of interest and creating effective therapies is the foundation of drug discovery. The company provides value to its pharmaceutical clients through hybridoma technology, phage display, and yeast display, which are advanced methods of antibody discovery.
“During the critical stages of antibody drug development, we conduct effective antibody screening and optimization and provide the pharmaceutical companies with high-affinity and high-specificity antibodies in a much quicker way,” explained the Chief Scientist of Creative Biolabs.
The company uses phage and yeast display as well as DNA mutagenesis methods to screen antibodies during antibody humanization and affinity maturation. This process improves not only the affinity and specificity of the antibodies but also their stability. This enables pharmaceutical companies to best select antibody molecules at the preclinical phase.
“Our focus in antibody development lies in its humanization and affinity maturation. This allows for minimal immunogenicity and maximal therapeutic efficacy of antibody drugs,” the scientist stated.
Creative Biolabs also provides OEM services for the manufacturing of large-scale antibody production using various platforms like bacterial and mammalian cell expression systems. The company offers efficient production of scFv, bispecific antibodies, tandem scFv, mini antibodies, and Fab due to its experience to avoid common obstacles in drug development.
End-to-End Assistance—From Discovery to Clinical
Creative Biolabs offers fully tailored solutions for pharmaceutical companies ranging from early discovery all the way to preclinical research. Creative Biolabs guarantees high-quality data provision and technical support for all phases of antibody screening, expression, purification, subsequent functional evaluations, and even animal model validation.
“Beyond technical service provision, we seek to collaborate with the pharmaceutical industry to ensure a seamless transition from idea to clinical trial,” said the scientist.
Creative Biolabs: Core Values and Philosophy
Creative Biolabs considers that a business model based on tailored services is key to optimizing processes in drug development, improving efficiency in R&D, and expanding drug discovery. The company’s ultimate objective is to facilitate the processes in drug development by offering active and flexible technology platforms that provide complete assistance to pharmaceutical companies from initial discoveries to preclinical studies.
For more information, visit https://www.creative-biolabs.com/.
